Reduction in the hepatocellular carcinoma antioncogene SLC39A14 during the malignant progression of hepatocellular carcinoma

Figure 6 Changes in SLC39A14 expression during hepatocellular carcinoma progression. A batch of mice was collected every 2 weeks during the induction process, and western blotting was performed to detect the changes in ZIP14 protein expression during the development of hepatocellular carcinoma (n = 8). ^aP < 0.05, ^bP < 0.01, ^cP < 0.0001.